Cutler Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,460
Closed -$96K 4438
2022
Q4
$96K Sell
3,460
-4,687
-58% -$120K 0.01% 1175
2022
Q3
$190K Buy
8,147
+1,230
+18% +$37.1K 0.01% 989
2022
Q2
$233K Buy
6,917
+3,767
+120% +$132K 0.02% 920
2022
Q1
$110K Buy
3,150
+2,240
+246% +$76.6K 0.01% 1626
2021
Q4
$27K Buy
+910
New +$29.6K ﹤0.01% 2887
2021
Q3
Sell
-7,812
Closed -$236K 6168
2021
Q2
$236K Buy
+7,812
New +$257K 0.01% 1234

Other funds holding OGN

Cutler Group's OGN Position: Q1 2023 in Review

Cutler Group sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 3,460 shares — an estimated $96K sold.

Cutler Group first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $236K in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Cutler Group reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 3,460 Organon & Co shares in Q1 2023, an estimated $96K.
  • Cutler Group first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Cutler Group's Organon & Co position peaked at $236K in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.